Show simple item record

dc.contributor.author Muntean, Marina
dc.contributor.author Vîslouh, Oxana
dc.date.accessioned 2021-12-10T08:48:36Z
dc.date.available 2021-12-10T08:48:36Z
dc.date.issued 2014
dc.identifier.citation Muntean Marina, Vîslouh Oxana. Particularities of validation HPLC method dosing. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 243. en_US
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/19350
dc.description Department of Pharmaceutical and Toxicological chemistry, State Medical and Pharmaceutical University “Nicolae Testemitanu”, Faculty of Pharmacy en_US
dc.description.abstract Introduction: Chromatographic methods are commonly used for the quantitative and qualitative analysis of raw materials, drug substances, drug products and compounds in biological fluids. Validation of a method is the process by which a method is tested by the developer or user for reliability, accuracy and preciseness of its intended purpose. Materials and methods: Advanced bibliographic study. Results: Though many types of HPLC techniques are available; the most commonly submitted method, the reversed-phase HPLC with UV detection, is selected to illustrate the parameters for validation. A. Accuracy is the measure of how close the experimental value is to the true value. Accuracy studies for drug substance and drug product are recommended to be performed at 80-100 and 120% levels of label claim as stated in the Guideline for Submitting Samples and Analytical Data for Methods Validation. B. Limit of Detection and Limit of Quantitation specifications are submitted with the regulatory impurities method relating to release and stability of both drug substance and drug product. C. Linearity range of detectability that obeys Beer's Law is dependent on the compound analyzed and detector used. D. Precision is the measure, that expresses the closeness of data values between a series of measurements obtained under unchanged analytical conditions. E. Range is the interval between the upper and lower levels of analyte studied. F. Recovery is defined as the observed result obtained from an amount of the analyts compared to the expected result obtained from theoretical amount and expressed as a percentage. G. Robustness is defined by ICH as a measure of the method's capability to remain unaffected by small, but deliberate variations in method parameters. H. Sample Solution Stability of the drug substance or drug product after preparation according to the test method should be evaluated according to the test method.I. Specificity/selectivity: the analyte should have no interference from other extraneous components and be well resolved from them. J. System Suitability Specifications and Tests are parameters that provide assistance in achieving this purpose. These parameters will be used to validate the method of assay of cinnamic acid from Tolu Balm in tablets. Conclusions: The variations due to the drug product manufacturing process, the laboratory sample preparation procedure and the performance instrument contribute to the accuracy of the data obtained from the analysis. Only with good reliable validated methods, data, generated for release, stability, and pharmacokinetics, can be trust-worthy. en_US
dc.language.iso en en_US
dc.publisher Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association en_US
dc.relation.ispartof MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova en_US
dc.subject HPLC en_US
dc.subject accuracy en_US
dc.subject detection limit en_US
dc.subject linearity en_US
dc.subject precision en_US
dc.subject range en_US
dc.subject recovery en_US
dc.subject robustness en_US
dc.subject stability en_US
dc.subject specificity en_US
dc.title Particularities of validation HPLC method dosing en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2014
    The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics